Clinical Trial Diversity in Colombia

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Clinical Trial Diversity in Colombia

Clinical Trial Diversity in Colombia – Clinical Trials in Latin America

Clinical trials serve as the foundation of medical research, leading to groundbreaking advancements in healthcare. However, the underrepresentation of diverse populations within these trials poses a significant challenge.

In Colombia, ensuring clinical trial diversity is of paramount importance to bridge healthcare disparities and ensure equitable access to innovative treatments.

This blog delves into the significance of clinical trial diversity, explores the barriers faced in Colombia, and proposes strategies to promote inclusivity and representation within the country’s clinical research landscape.

Importance of Clinical Trial Diversity

Clinical trial diversity involves the inclusion of individuals from various racial, ethnic, age, gender, and socioeconomic backgrounds in research studies. It plays a critical role in advancing medical knowledge for several reasons.

Firstly, diverse populations possess genetic, environmental, and lifestyle differences that impact disease susceptibility, treatment response, and adverse reactions.

By including a broad range of participants, clinical trials can generate robust data that accurately represents real-world patient populations, resulting in more effective and personalized healthcare interventions.

Secondly, clinical trial diversity promotes equity in healthcare. Historically marginalized communities, including ethnic minorities, have faced disparities in access to quality healthcare.

By actively involving underrepresented populations in research, clinical trials can uncover potential variations in treatment outcomes, safety profiles, and adverse effects across different groups. This knowledge enables healthcare providers to deliver tailored interventions and improve health outcomes for all.

Barriers to Diversity in Colombian Clinical Trials

Colombia faces several barriers to achieving diversity in clinical trials. Firstly, limited awareness and knowledge about clinical research among the general population hinder participation rates. Misconceptions, lack of trust, and fear of exploitation are common reasons why individuals from diverse backgrounds may hesitate to engage in clinical trials.

Language and cultural barriers are additional challenges. Colombia is a country with significant linguistic and cultural diversity. Ensuring accurate translation and culturally sensitive communication materials are essential to foster trust and engagement among potential participants.

Socioeconomic factors also play a role in limiting diversity in clinical trials. Limited access to healthcare facilities, financial constraints, and lack of insurance coverage may deter individuals from underprivileged backgrounds from participating. Addressing these barriers requires providing resources for transportation, offering financial support, and ensuring equitable access to clinical trial opportunities.

Clinical Trial Diversity in Colombia

Clinical Trial Diversity in Colombia

Clinical Trial Diversity in Colombia

Building Trust and Encouraging Diversity

To overcome these barriers, concerted efforts are necessary to enhance clinical trial diversity in Colombia. Building trust within communities is a fundamental step. Engaging with community leaders, patient advocacy groups, and local organizations can help establish meaningful relationships.

Open and transparent communication about the purpose, process, and potential benefits of clinical trials is crucial to dispel myths and address concerns.

Educational campaigns can play a pivotal role in promoting clinical trial participation. These campaigns should emphasize the importance of diverse representation, showcase success stories, and provide accurate information to empower individuals to make informed decisions.

Collaborating with trusted healthcare providers and community influencers can significantly boost awareness and participation rates.

Improving accessibility to clinical trials is another critical aspect. Expanding trial sites to underserved areas and ensuring adequate representation across different regions of Colombia can encourage participation from diverse populations.

Additionally, simplifying the enrollment process and providing support for participants, such as transportation assistance and reimbursement of expenses, can alleviate financial burdens.

To promote diversity, it is essential to enhance cultural competency within the research workforce. Encouraging diversity in research teams and providing training on cultural sensitivity and inclusive practices can foster an environment where participants feel understood and respected.


Promoting diversity in clinical trials is crucial for advancing healthcare in Colombia. By addressing barriers to participation, fostering trust, and promoting awareness, Colombia can achieve greater representation within clinical research studies.

This inclusivity will lead to more comprehensive and accurate data, enabling healthcare professionals to develop tailored treatments and interventions that cater to the diverse needs of the population.

Regulatory bodies and research institutions should play an active role in promoting diversity in clinical trials. They can establish guidelines and policies that encourage and incentivize inclusive research practices. Funding agencies can prioritize projects that prioritize diversity and inclusion, ensuring that resources are allocated to studies that reflect the population’s diversity.

Clinical Trial Diversity in Colombia

Source: Pro Colombia

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Clinical Trial Diversity in Colombia

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Clinical Trial Diversity in Colombia

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Clinical Trial Diversity in Colombia

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Clinical Trial Diversity in Colombia

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Clinical Trial Diversity in Colombia

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Clinical Trial Diversity in Colombia

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Clinical Trial Diversity in Colombia

The Cohortias Team

Clinical Trial Diversity in Colombia

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Clinical Trial Diversity in Colombia

Network & Partnerships